|
gptkbp:instanceOf
|
Biotechnology company
|
|
gptkbp:acquisition
|
Acquired_by_PerkinElmer
|
|
gptkbp:awards
|
gptkb:Queen's_Award_for_Enterprise
Best Company to Work For
Fastest_Growing_Company
|
|
gptkbp:customerBase
|
Academic institutions
Research organizations
Pharmaceutical companies
Biotech_companies
|
|
gptkbp:employeeCount
|
Over 200
|
|
gptkbp:founded
|
2007
|
|
gptkbp:founder
|
gptkb:Darrin_Disley
|
|
gptkbp:headquarters
|
gptkb:Cambridge,_United_Kingdom
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Horizon Discovery Group
|
|
gptkbp:industry
|
Biotechnology
|
|
gptkbp:location
|
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:market
|
gptkb:Asia
gptkb:North_America
Europe
Global
|
|
gptkbp:parentCompany
|
gptkb:PerkinElmer,_Inc.
|
|
gptkbp:partnerships
|
gptkb:Harvard_University
gptkb:University_of_Cambridge
gptkb:University_of_Oxford
gptkb:MIT
|
|
gptkbp:products
|
Gene_editing_tools
|
|
gptkbp:researchFocus
|
Cancer research
Drug discovery
Therapeutics
Genetic diseases
|
|
gptkbp:revenue
|
£30 million (2020)
|
|
gptkbp:services
|
Genetic engineering
Cell line development
|
|
gptkbp:specialization
|
CRISPR technology
Cell line engineering
Gene modulation
|
|
gptkbp:stockSymbol
|
HZD
|
|
gptkbp:subsidiary
|
gptkb:Horizon_Discovery,_Inc.
gptkb:Horizon_Discovery_(UK)_Limited
gptkb:Horizon_Discovery_(US)_LLC
|
|
gptkbp:technology
|
RNA interference
CRISPR-Cas9
Transgenic models
Gene_editing
|
|
gptkbp:website
|
www.horizondiscovery.com
|